Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial

BACKGROUND: This post hoc analysis examined the efficacy and safety of twice-daily insulin lispro low mixture (LM25) and once-daily basal insulin glargine plus once-daily prandial insulin lispro (IGL) in a Latin American subpopulation with type 2 diabetes mellitus (T2DM). METHODS: A phase 4, randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas, Arturo, Sposetti, Georgina, Gross, Jorge L., Barbieri, Douglas Eugenio, Duan, Ran, Linetzky, Bruno, De Lana, Janaina Martins, Stempa, Oded, Rodriguez, Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027076/
https://www.ncbi.nlm.nih.gov/pubmed/27660663
http://dx.doi.org/10.1186/s13098-016-0163-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027076/
https://www.ncbi.nlm.nih.gov/pubmed/27660663
http://dx.doi.org/10.1186/s13098-016-0163-3

Ejemplares similares